News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
In Fight Against Alzheimer's, $100 Million Genentech (RHHBY) Trial in Colombia May Be Ground Zero     4/27/2015
Roche (RHHBY) Still Bullish on Alzheimer’s Research After Biogen (BIIB)’s Successful Clinical Trial     4/22/2015
Targacept (TRGT) Winces As Last Remaining Drug Candidate Flops in Phase II Trial     4/17/2015
Raising $10M in Series A, Alzheon CEO Bets He Can Beat Biogen (BIIB) With World's First Alzheimer's Drug     4/8/2015
AstraZeneca PLC (AZN)'s Failed Cancer Drug Finds New Life in Alzheimer’s Treatment     4/3/2015
Amgen (AMGN)'s deCODE genetics (DCGN) Publishes Largest Human Genome Population Study     3/27/2015
New Research Throws Cold Water on Biogen (BIIB)'s Recent Breakthrough     3/26/2015
Biogen (BIIB) Alzheimer's Drug Aducanumab Exceeds Expectations     3/25/2015
Biogen (BIIB) Drops Idec From Corporate Name, Expands Ambitions in Alzheimer's, ALS     3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY)     3/23/2015
Expectations are High as Biogen Idec (BIIB) Prepares to Reveal Alzheimer's Data     3/18/2015
Big Names Such as GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), and Pfizer (PFE) Invest in $100 Million Alzheimer's Venture Fund     3/18/2015
Biogen Idec (BIIB) Will Be Hiring in R&D After Around 20 Employees Leave Following Review     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
EXCLUSIVE: AgeneBio CEO Says Delays in Alzheimer's Onset Could Save Millions, As Paradigm Shifts     3/12/2015

News from Around the Web
Can Biogen (BIIB) Really Beat Alzheimer's?     4/24/2015
Extra Sleep May Restore Memory And Stall Alzheimer’s-Like Condition, Washington University School of Medicine Study     4/24/2015
Brain Scans Give Clues to Link Between Alzheimer's, Down Syndrome, Alzheimer's & Dementia Reveals     4/21/2015
Targacept (TRGT) Abandons Nictoine Focus for Alzheimer's     4/6/2015
Common Epilepsy Drug Restores Brain Function And Memory In Early Alzheimer’s, Johns Hopkins University Study     3/13/2015
Poor Heart Function Could Be Major Alzheimer's Disease Risk, Vanderbilt University Study     3/4/2015
Can Coffee Cut Your MS Risk? Johns Hopkins University Study     3/2/2015
Type 2 Diabetes May Boost Alzheimer's Risk, Uppsala Universitet Study     2/19/2015
Autism, Alzheimer’s Affect Genders Differently, Tel Aviv University Study     2/5/2015
Drink Beer To Ward Off Alzheimer’s And Parkinson’s, Lanzhou University Study     1/30/2015
Diet Affects Brain Iron Levels Differently In Men And Women, University at Buffalo Study Shows     1/27/2015
Common Mood Changes May Signal Early Alzheimer’s, Washington University School of Medicine Study     1/15/2015
Natural Product Found In Turmeric May Fight Alzheimer’s, Vanderbilt University Reveals     1/14/2015
Nasal Spray May Cure Dementia And Alzheimer's, Wake Forest University Baptist Medical Center Study     1/13/2015
Top Medical Advances Of 2014     1/5/2015

Press Releases
The ALS Association, Harvard Stem Cell Institute, And Massachusetts General Hospital Neurological Clinical Research Institute Collaborate With GlaxoSmithKline (GSK) On New ALS Clinical Trial     4/16/2015
Alzheimer's Association Release: Major New Research Study To Demonstrate Value Of PET Scans In Alzheimer's Disease Diagnosis     4/16/2015
Our Vision Is To Cure Alzheimer’s Disease: Health Connexions And Recombinant Technologies Announce A Ground-Breaking Partnership To Accelerate Success In Alzheimer’s Disease     4/7/2015
Neurotrope Selects Worldwide Clinical Trials To Commence Services For Phase 2B Trial Of Bryostatin For The Treatment Of Alzheimer's Disease     4/6/2015
Alzheimer's Drug Discovery Foundation Funds Signum Biosciences to Move Novel Therapeutics Towards Clinic     3/31/2015
New Alzheimer's Association Report Finds Less Than Half of People with Alzheimer's Disease Say They Were Told the Diagnosis     3/24/2015
UPDATE: President & CEO Nikolaos Tezapsidis, Ph.D., Of Neurotez, Inc. To Be Interviewed Live On Clear Channel's "The Trader's Network Show"     3/23/2015
Anavex (AVXL) Presents Positive Results For Both ANAVEX 2-73 And ANAVEX 3-71 In Alzheimer's Models At 2015 AD/PD Conference     3/23/2015
Alzheon Announces Phase 1 Results Of ALZ-801, A First-in-Class Inhibitor Of Amyloid Formation And Neurotoxicity For Alzheimer’s Disease     3/20/2015
Biogen Idec (BIIB) Presents Positive Interim Results From Phase 1B Study Of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) At 2015 AD/PD Conference     3/20/2015
AbbVie (ABBV) And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy     3/19/2015
GAP And IMI To Sign MOU To Accelerate Alzheimer's Drug Development     3/19/2015
Neurotrope Announces Positive Final Results From its Phase 2a Safety Study for the Treatment of Alzheimer's Disease     3/17/2015
The ALS Association Welcomes ALS Of Nevada As The Nevada Chapter To Help People Living With ALS Throughout The State Of Nevada     3/17/2015
AD/PD 2015 Showcases The Latest Research And New Therapies In Alzheimer's, Parkinson's And Related Brain Diseases     3/16/2015

//-->